Crinetics Pharmaceuticals Inc. Share Price Today, Forecast Target, Chat & Where To Buy [CRNX]

Home > Share Prices > Crinetics Pharmaceuticals Inc. share price (CRNX)

Today's Crinetics Pharmaceuticals Inc. share price is 45.76 (as of 16:00 09-Oct-2025) which is a change of 1.33 or 2.99% from the last closing price of 45.76 with 86 shares traded giving Crinetics Pharmaceuticals Inc. a market capitalisation of 4,309,492,686. The most recent daily high has been 45.88 and daily low 44.1. The Crinetics Pharmaceuticals Inc. share price 52 week high has been 62.53 and the 52 week low 24.1. Based on the most recent Crinetics Pharmaceuticals Inc. share price opening of 45.76, the current Crinetics Pharmaceuticals Inc. EPS (earnings per share) are -4.11 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying Crinetics Pharmaceuticals Inc. Shares

It currently costs 45.76 to buy one share in Crinetics Pharmaceuticals Inc. (as of 16:00 09-Oct-2025) which is a change of 1.33 or 2.99% from the last closing price of 44.43. To buy shares in Crinetics Pharmaceuticals Inc. you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Crinetics Pharmaceuticals Inc. A Good Investment?

The below Crinetics Pharmaceuticals Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top